Chronic Graft Versus Host Disease (cGvHD) Latest Advances
Find the Latest Research About Chronic Graft Versus Host Disease (cGvHD)
Last Updated: 06/24/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1443 publications
Salvage nintedanib plus low-dose ruxolitinib therapy for bronchiolitis obliterans syndrome refractory to calcineurin inhibitors and glucocorticoids after allogeneic transplantation.
Journal: Cell transplantation
Published: April 04, 2026
Alpha 1 Antitrypsin Suppresses Autoantibody Production and Cellular Autoimmunity in Chronic Graft-Versus-Host Disease (cGVHD) in a Lupus Mouse Model.
Journal: Biomolecules
Published: January 28, 2026
Ruxolitinib as a Steroid-Sparing Treatment for Chronic Graft vs Host Disease.
Journal: Transplantation and cellular therapy
Published: January 14, 2026
Chronic graft-versus-host disease: Current situation and unmet needs - A European position statement.
Journal: Bone marrow transplantation
Published: December 24, 2025
Transportability to the European population of Efficacy of Belumosudil as Compared with Physician's Choice of Best Available Therapy for The Treatment of Chronic Graft Versus Host Disease.
Journal: Transplantation and cellular therapy
Published: December 19, 2025
The Effect of Smoking and Pre-Allogeneic Hematopoietic Cell Transplant Pulmonary Comorbidity on the Incidence of Lung Graft-Versus-Host Disease and Post-Transplant Outcomes.
Journal: Cancers
Published: November 26, 2025
Spanish real-world experience with belumosudil for chronic graft-versus-host disease after two or more prior lines of therapy.
Journal: Transplantation and cellular therapy
Published: November 12, 2025
Clinical Characteristics and Treatment Outcomes of Autoimmune-Like Hepatitis After Allogeneic Hematopoietic Stem Cell Transplantation.
Journal: Transplantation and cellular therapy
Published: November 04, 2025
Strategies for the diagnosis and treatment of pulmonary chronic graft-versus-host disease after hematopoietic stem cell transplantation
Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
Published: October 14, 2025
Belumosudil for Chronic Graft-Versus-Host Disease: A Systematic Review and Meta-Analysis.
Journal: Transplantation and cellular therapy
Published: October 03, 2025
Efficacy and safety of belumosudil for refractory chronic graft-versus-host disease in routine practice.
Journal: Annals of hematology
Published: September 29, 2025
Real world experience using belumosudil for treatment of chronic graft versus host disease in children and young adults.
Journal: Bone marrow transplantation
Published: September 11, 2025
Last Updated: 06/24/2026